AAAAAA
Results: 1-25/87
Authors:
MESSERLI F
FRISHMAN WH
ELLIOTT WJ
Citation: F. Messerli et al., EFFECTS OF VERAPAMIL AND TRANDOLAPRIL IN THE TREATMENT OF HYPERTENSION, American journal of hypertension, 11(3), 1998, pp. 322-327
Authors:
FRISHMAN WH
WEISEN SF
WASSERTHEILSMOLLER S
ARONSON M
Citation: Wh. Frishman et al., SELF-RATED HEALTH ASSESSMENT AND THE DEVELOPMENT OF CARDIOVASCULAR AND DEMENTING ILLNESSES IN THE OLD - A REPORT FROM THE BRONX LONGITUDINAL AGING STUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 129-129
Authors:
FRISHMAN WH
BITTAR N
GLASSER S
HABIB G
SMITH W
PORDY R
Citation: Wh. Frishman et al., ADDITIONAL ANTIANGINAL AND ANTIISCHEMIC EFFICACY OF MIBEFRADIL IN PATIENTS CONCOMITANTLY TREATED WITH LONG-ACTING NITRATES FOR CHRONIC STABLE ANGINA-PECTORIS, Clinical cardiology, 21(7), 1998, pp. 483-490
Authors:
FRISHMAN WH
GOMBERGMAITLAND M
HIRSCH H
CATANESE J
FURIAPALAZZO S
MUELLER H
STEINGART R
FORMAN S
Citation: Wh. Frishman et al., DIFFERENCES BETWEEN MALE AND FEMALE-PATIENTS WITH REGARD TO BASE-LINEDEMOGRAPHICS AND CLINICAL OUTCOMES IN THE ASYMPTOMATIC CARDIAC ISCHEMIA PILOT (ACIP) TRIAL, Clinical cardiology, 21(3), 1998, pp. 184-190
Authors:
FRISHMAN WH
SOKOL S
ARONSON MK
WASSERTHEILSMOLLER S
KATZMAN R
Citation: Wh. Frishman et al., RISK-FACTORS FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES AND DEMENTIA IN THE ELDERLY, Current problems in cardiology, 23(1), 1998, pp. 7-62
Authors:
FRISHMAN WH
VAHDAT S
BHATTA S
Citation: Wh. Frishman et al., INNOVATIVE PHARMACOLOGICAL APPROACHES TO CARDIOPULMONARY-RESUSCITATION, Journal of clinical pharmacology, 38(9), 1998, pp. 765-772
Authors:
CHENG A
FRISHMAN WH
Citation: A. Cheng et Wh. Frishman, USE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AS MONOTHERAPY AND INCOMBINATION WITH DIURETICS AND CALCIUM-CHANNEL BLOCKERS, Journal of clinical pharmacology, 38(6), 1998, pp. 477-491
Authors:
YASHAR PR
FRANSUA M
FRISHMAN WH
Citation: Pr. Yashar et al., THE SODIUM-CALCIUM ION MEMBRANE EXCHANGER - PHYSIOLOGICAL SIGNIFICANCE AND PHARMACOLOGICAL IMPLICATIONS, Journal of clinical pharmacology, 38(5), 1998, pp. 393-401
Authors:
ANANDASABAPATHY S
FRISHMAN WH
Citation: S. Anandasabapathy et Wh. Frishman, INNOVATIVE DRUG TREATMENTS FOR VIRAL AND AUTOIMMUNE MYOCARDITIS, Journal of clinical pharmacology, 38(4), 1998, pp. 295-308
Authors:
ELIHU N
ANANDASBAPATHY S
FRISHMAN WH
Citation: N. Elihu et al., CHELATION-THERAPY IN CARDIOVASCULAR-DISEASE - ETHYLENEDIAMINETETRAACETIC ACID, DEFEROXAMINE, AND DEXRAZOXANE, Journal of clinical pharmacology, 38(2), 1998, pp. 101-105
Authors:
LEVITSKY J
GURELL D
FRISHMAN WH
Citation: J. Levitsky et al., SODIUM-ION HYDROGEN-ION EXCHANGE INHIBITION - A NEW PHARMACOLOGICAL APPROACH TO MYOCARDIAL-ISCHEMIA AND REPERFUSION INJURY, Journal of clinical pharmacology, 38(10), 1998, pp. 887-897
Authors:
POST JB
FRISHMAN WH
Citation: Jb. Post et Wh. Frishman, FENOLDOPAM - A NEW DOPAMINE AGONIST FOR THE TREATMENT OF HYPERTENSIVEURGENCIES AND EMERGENCIES, Journal of clinical pharmacology, 38(1), 1998, pp. 2-13
Authors:
MASHOUR NH
LIN GI
FRISHMAN WH
Citation: Nh. Mashour et al., HERBAL MEDICINE FOR THE TREATMENT OF CARDIOVASCULAR-DISEASE - CLINICAL CONSIDERATIONS, Archives of internal medicine, 158(20), 1998, pp. 2225-2234
Authors:
ROBERTS WC
FRISHMAN WH
Citation: Wc. Roberts et Wh. Frishman, FRISHMAN,WILLIAM,HOWARD, MD - A CONVERSATION WITH THE EDITOR, The American journal of cardiology, 81(11), 1998, pp. 1323
Authors:
GOMBERGMAITLAND M
FRISHMAN WH
Citation: M. Gombergmaitland et Wh. Frishman, THYROID-HORMONE AND CARDIOVASCULAR-DISEASE, The American heart journal, 135(2), 1998, pp. 187-196
Authors:
BERNSTEIN JM
FRISHMAN WH
CHANG CJ
Citation: Jm. Bernstein et al., VALUE OF ECG P-R AND Q-TC INTERVAL PROLONGATION AND HEART-RATE-VARIABILITY FOR PREDICTING CARDIOVASCULAR MORBIDITY AND MORTALITY IN THE ELDERLY - THE BRONX AGING STUDY, Cardiology in the elderly, 5(1), 1997, pp. 31-41
Authors:
FRISHMAN WH
Citation: Wh. Frishman, RESULTS OF HYPERTENSION TREATMENT WITH LOW-DOSE COMBINATIONS OF A BETA-ADRENERGIC BLOCKER AND A DIURETIC, American journal of hypertension, 10(3), 1997, pp. 17-23
Authors:
NEUTEL J
ABERNETHY DR
MOSER M
GIFFORD RW
FRISHMAN WH
Citation: J. Neutel et al., DISCUSSION - RECENT DATA ON THE SAFETY AND EFFICACY OF NEWER THERAPIES IN THE MANAGEMENT OF HYPERTENSION, American journal of hypertension, 10(3), 1997, pp. 24-26
Authors:
HELLER GV
SRIDHARAN M
MORSE J
GLASSER S
BEACH CL
BLOOMFIELD DA
BLUMFIELD DE
DAMORE S
EMMOT WW
FRIEDMAN RG
FRISHMAN WH
FROEHLICH RT
GLASSER SP
GOLDSCHER DA
GROSSMAN WJ
KUSHNER FG
LIEBERMAN LJ
NIEDERMAN AL
SCHMITZ JM
SPRINKLE LW
STEINER C
WEIR EK
YOUNG DJ
ZELLNER SR
Citation: Gv. Heller et al., ANTIANGINAL RESPONSE TO ONCE-DAILY DILTIAZEM CD IN PATIENTS RECEIVINGCONCOMITANT BETA-BLOCKERS, LONG-ACTING NITRATES, OR BOTH, Pharmacotherapy, 17(4), 1997, pp. 760-766
Authors:
NEUTEL JM
SMITH DHG
FRISHMAN WH
Citation: Jm. Neutel et al., OPTIMIZATION OF ANTIHYPERTENSIVE THERAPY WITH A NOVEL, EXTENDED-RELEASE FORMULATION OF DILTIAZEM - RESULTS OF A PRACTICE-BASED CLINICAL-STUDY, Clinical therapeutics, 19(6), 1997, pp. 1379-1393
Authors:
FRISHMAN WH
YEE HCM
KEEFE D
DUTCHER J
SUNG HM
LIU LL
EINZIG AI
Citation: Wh. Frishman et al., CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY, Current problems in cancer, 21(6), 1997, pp. 308-360
Authors:
WEISER M
FRISHMAN WH
MICHAELSON MD
ABDEEN MA
Citation: M. Weiser et al., THE PHARMACOLOGICAL APPROACH TO THE TREATMENT OF OBESITY, Journal of clinical pharmacology, 37(6), 1997, pp. 453-473
Authors:
CELENTANO DC
FRISHMAN WH
Citation: Dc. Celentano et Wh. Frishman, MATRIX METALLOPROTEINASES AND CORONARY-ARTERY DISEASE - A NOVEL THERAPEUTIC TARGET, Journal of clinical pharmacology, 37(11), 1997, pp. 991-1000
Authors:
LANDZBERG BR
FRISHMAN WH
LERRICK K
Citation: Br. Landzberg et al., PATHOPHYSIOLOGY AND PHARMACOLOGICAL APPROACHES FOR PREVENTION OF CORONARY-ARTERY RESTENOSIS FOLLOWING CORONARY-ARTERY BALLOON ANGIOPLASTY AND RELATED PROCEDURES, Progress in cardiovascular diseases, 39(4), 1997, pp. 361-398
Authors:
FRISHMAN WH
STONE PH
GLASSER SP
BRYZINSKI BS
FAKOUHI TD
Citation: Wh. Frishman et al., A PLACEBO-CONTROLLED MULTICENTER COMPARISON OF A PHYSIOLOGICAL PATTERN RELEASE FORMULATION OF VERAPAMIL TO AMLODIPINE AND AMLODIPINE PLUS ATENOLOL IN PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS, Circulation, 96(8), 1997, pp. 2605-2605